GGrantIndex
Sort

130,381 grants matching hiv

The Oral Mucosa in HIV Disease: Innate Immunity

$869,959
Nina Agabian · University Of California, San Francisco · P01 · FY2006 · DE

Optimizing PrEP adherence in sexual minority men who use stimulants

$869,958
Adam Wayne Carrico · Florida International University · R01 · FY2024 · DA

Northern California Pediatrics AIDS Treatment Center

$869,956
University Of California San Francisco · U01 · FY2005 · AI

HIV Reservoir Ecology of Viral Remission

$869,936
Jonathan Li · Brigham And Women'S Hospital · R01 · FY2024 · AI

HIV PREVENTION PROJECTS

$869,899
Jesus Sandoval · Idaho State Dept Of Health And Welfare · U62 · FY2006 · PS

HIV and musculoskeletal frailty: implications for care, policy and research

$869,878
Elena Losina · Brigham And Women'S Hospital · R01 · FY2024 · NR

Human Energy and Body Weight Regulation Core

$869,835
Kong Chen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2020 · DK

Immunologic and Fat-Associated Predictors of Insulin Resistance in Treated HIV

$869,817
Suneil Krishna Koliwad · University Of California, San Francisco · R01 · FY2020 · DK

Acute HIV infection - A key link for transmission prevention

$869,770
William C Miller · Univ Of North Carolina Chapel Hill · R01 · FY2009 · AI

Maximizing germinal centers and somatic hypermutation to HIV Env immunogens

$869,654
Shane P Crotty · La Jolla Institute For Immunology · R37 · FY2023 · AI

Theoretically Based Mobile App to Increase PrEP Uptake Among MSM

$869,614
Patrick Sean Sullivan · Emory University · R01 · FY2021 · DA

The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.

$869,573
Beatriz Grinsztejn · Fundacao Oswaldo Cruz · UM1 · FY2025 · AI

AVANTE ZAMBZIA: TECHNICAL ASSISTANCE TO THE MINISTRY OF HEALTH (MOH) FOR HIV SERV

$869,540
C. William Wester · Vanderbilt University · U2G · FY2014 · GH

Targeting PD-1 Pathway for Functional Cure of AIDS

$869,526
Rama Rao Amara · Emory University · R37 · FY2015 · AI

Neuroimmune pathways linking chronic psychosocial stress to co-occurring stimulant use and depression in HIV disease: a mechanistic clinical trial

$869,488
Christina S Meade · Wake Forest University Health Sciences · R01 · FY2024 · DA

PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS

$869,405
Jennifer L Vandevelde · Kansas State Dept Of Hlth And Environmnt · U62 · FY2015 · PS

Development of Aersolized Vaccines

$869,351
Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Improving HIV Service Delivery for People who Inject Drugs in Kazakhstan

$869,302
Nabila El-Bassel · Columbia Univ New York Morningside · R01 · FY2015 · DA

Stress Management of Cryptococcal Pathogens

$869,294
Kyung Kwon-Chung · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Enhanced HIV Prevention in the Republic of Uganda under the President's Emergency

$869,270
Edward Katongole Mbidde · Uganda Virus Research Institute · U2G · FY2015 · GH

Human Genetic Dissection of Exit from Latency in Tuberculosis

$869,244
Jean-Laurent Casanova · Weill Medical Coll Of Cornell Univ · U19 · FY2016 · AI

Functional And Phenotypic Characterization Of T Cells In Man

$869,227
Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Impact of Interventions on Clonally Expanded Proviruses and Their RNA Expression

$869,203
Mary Kearney · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

R5 SHIV/Macaque Models for the Evaluation of T and B Cell-Based HIV-1 Vaccines

$869,155
Cecilia C Cheng-Mayer · Aaron Diamond Aids Research Center · R01 · FY2010 · AI

Central memory CD4 T cell infection: key role in ART response and HIV persistence

$869,119
Mirko Paiardini · Emory University · R01 · FY2016 · AI